All Stories

  1. Editorial Comment to Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database
  2. Editorial Comment to Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?
  3. Editorial Comment to Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy
  4. Editorial Comment from Dr Mearini to Postoperative prostate-specific antigen monitoring interval for radical prostatectomy patients with low recurrence risk
  5. 67 Abdominal versus laparoscopic sacrocolpopexy: A randomized controlled trial
  6. 73 Pelvic organ prolapse surgery: The S.A.C.S. (Satisfaction–Anatomy–Continence– Safety) as outcome scoring system
  7. MP81-18 ABDOMINAL VS LAPAROSCOPIC SACROCOLPOPEXY: A RANDOMIZED CONTROLLED TRIAL
  8. Use of the Prostate Health Index for the Detection of Aggressive Prostate Cancer at Radical Prostatectomy
  9. The S.A.C.S. (Satisfaction–Anatomy–Continence–Safety) score for evaluating pelvic organ prolapse surgery: a proposal for an outcome-based scoring system
  10. Editorial Comment
  11. High-intensity focused ultrasound for the treatment of prostate cancer: A prospective trial with long-term follow-up
  12. Ureteroarterial Fistula from Ureteral Stump: A Challenging Case
  13. Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer
  14. Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study
  15. External Validation of Nomogram Predicting the Probability of Specimen-Confined Disease (pT2-3a, R0N0) in Patients Undergoing Radical Prostatectomy and Pelvic Lymph Node Dissection
  16. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes
  17. Editorial Comment to Bone dissemination of prostate cancer after holmium laser enucleation of the prostate: A case report and a review of the literature
  18. 933 In vivo tissue-engineered augmentation cystoplasty with electrospun scaffold made of PCL and PHA: 6 months results in rats
  19. Changes in female sexual function after pelvic organ prolapse repair: role of hysterectomy
  20. High intensity focused ultrasound, liver disease and bridging therapy
  21. Adrenal Oncocytic Neoplasm: A Systematic Review
  22. Urgency, Detrusor Overactivity and Posterior Vault Prolapse in Women Who Underwent Pelvic Organ Prolapse Repair
  23. Perugia ileal neobladder: functional results and complications
  24. Conformal Postoperative Radiotherapy in Patients With Positive Resection Margins and/or pT3-4 Prostate Adenocarcinoma
  25. A review of penile metastasis
  26. Editorial Comment
  27. Editorial Comment to Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis
  28. 2142 SEXUAL CHANGES AFTER POP REPAIR. IS HYSTERECTOMY A KEY ELEMENT ?
  29. 1872 PREOPERATIVE URINARY INCONTINENCE IS THE MAIN RISK FACTOR FOR POST-OPERATIVE INCONTINENCE IN WOMEN WHO UNDERWENT PELVIC ORGAN PROLAPSE REPAIR
  30. 586 Sexual changes after POP repair. Is hysterectomy a key element?
  31. 527 Preoperative urinary incontinence is the main risk factor for post-operative incontinence in women who underwent pelvic organ prolapse repair
  32. 528 Surgical correction of uro-genital prolapse: A randomized trial of open surgery vs laparoscopy. Preliminary report
  33. Botulinum Toxin a in Prostate Disease: A Venom from Bench to Bed-Side
  34. Low serum testosterone levels are predictive of prostate cancer
  35. Intermittent Androgen Suppression in Prostate Cancer: Testosterone Levels and Its Implication
  36. 1872 OVERACTIVE BLADDER SYMPTOMS (OAB) AND DETRUSOR OVERACTIVITY (DO) IN PATIENTS WITH POSTERIOR VAULT PROLAPSE: PREVALENCE AND ITS CHANGES AFTER POP REPAIR
  37. 480 PRULIFLOXACIN VS PHOSPHOMYCIN: PROPHYLAXIS IN PATIENTS WITH RECURRENT UTI. PRELIMINARY RESULTS OF A RANDOMIZED MULTI-CENTRE STUDY
  38. 53 OVERACTIVE BLADDER SYMPTOMS (OAB) AND DETRUSOR OVERACTIVITY (DO) IN PATIENTS WITH POSTERIOR VAULT PROLAPSE: PREVALENCE AND ITS CHANGES AFTER POP REPAIR
  39. Pros and Cons of Focal Therapy for Localised Prostate Cancer
  40. Five-year outcome of uterus sparing surgery for pelvic organ prolapse repair: a single-center experience
  41. Uterus preservation in pelvic organ prolapse surgery
  42. 1510 FEMALE SEXUAL FUNCTION EVALUATION IN PATIENTS UNDERWENT TO INTEGRAL PELVIC FLOOR RECONSTRUCTIVE SURGERY
  43. 395 LONG-TERM OUTCOME OF ANTI-INCONTINENCE PROCEDURE DURING PELVIC ORGAN PROLAPSE REPAIR IN PATIENTS WITH OR WITHOUT URINARY INCONTINENCE: RESULTS FROM TWO RANDOMISED SURGICAL TRIALS
  44. Iatrogenic Trapped Penis in Adults: New, Simple 2-Stage Repair
  45. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: Past, present, and future
  46. Outcomes of Radical Prostatectomy in Clinically Locally Advanced N0M0 Prostate Cancer
  47. Bacillus Calmette-Guérin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study
  48. LONG-TERM FOLLOW-UP OF UTERUS SPARING SURGERY FOR PELVIC ORGAN PROLAPSE (POP)
  49. IS SURGICAL OUTCOME AT RISK DURING POST-GRADUATED EDUCATIONAL COURSES FOR STRESS URINARY INCONTINENCE (SUI) AND PELVIC ORGAN PROLAPSE (POP) REPAIR? A CASE CONTROL STUDY
  50. 478 LONG-TERM FOLLOW-UP OF UTERUS SPARING SURGERY FOR PELVIC ORGAN PROLAPSE (POP)
  51. 481 IS SURGICAL OUTCOME AT RISK DURING POST-GRADUATED EDUCATIONAL COURSES FOR STRESS URINARY INCONTINENCE (SUI) AND PELVIC ORGAN PROLAPSE (POP) REPAIR? A CASE CONTROL STUDY
  52. Hydronephrosis and Pelvic Organ Prolapse
  53. Visually Directed Transrectal High Intensity Focused Ultrasound for the Treatment of Prostate Cancer: A Preliminary Report on the Italian Experience
  54. Bladder and Urethral Sphincter Function after Radical Retropubic Prostatectomy: A Prospective Long-Term Study
  55. PREOPERATIVE MUCP AND VLPP FAILED TO PREDICT OUTCOME IN PATIENTS WHO UNDERWENT TRANSOBTURATOR MID-URETHRAL SLINGS
  56. OUTCOME OF RADICAL PROSTATECTOMY IN LOCALLY ADVANCED, CN0 CM0 PROSTATE CANCER
  57. Botulinum A Toxin Intravesical Injection in Patients With Painful Bladder Syndrome: 1-Year Followup
  58. PREOPERATIVE MUCP AND VLPP FAILED TO PREDICT OUTCOME IN PATIENTS WHO UNDERWENT TRANSOBTURATOR MIDURETHRAL SLINGS
  59. TRANSRECTAL HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) USING THE SONABLATE®500 FOR THE TREATMENT OF PROSTATE CANCER; THE PERUGIA-TURIN EXPERIENCE
  60. Testosterone Levels in Benign Prostatic Hypertrophy and Prostate Cancer
  61. Sensitivity and Specificity of One-Hour Pad Test as a Predictive Value for Female Urinary Incontinence
  62. Female Sexual Dysfunction in Urogenital Prolapse Surgery: Colposacropexy vs. Hysterocolposacropexy
  63. Is There Any Clinical Parameter Able to Predict Prostate Cancer after Initial Diagnosis of Atypical Small Acinar Proliferation?
  64. Tension-Free Vaginal Tape versus Transobturator Tape as Surgery for Stress Urinary Incontinence: Results of a Multicentre Randomised Trial
  65. Voiding Dysfunction after Radical Retropubic Prostatectomy: More than External Urethral Sphincter Deficiency
  66. Must Colposuspension be Associated with Sacropexy to Prevent Postoperative Urinary Incontinence?
  67. 338 FEMALE SEXUAL DYSFUNCTION IN UROGENITAL PROLAPSE SURGERY: COLPOSACROPEXYVS. HYSTEROCOLPOSACROPEXY
  68. 827 A PROSPECTIVE RANDOMIZED TRIAL COMPARING TENSION-FREE VAGINAL TAPE AND TRANSOBTURATOR SUBURETHRAL TAPE FOR SURGICAL TREATMENT OF STRESS URINARY INCONTINENCE
  69. 866 SACROPEXY AND BURCH COLPOSUSPENSION FOR PELVIC ORGAN PROLAPSE ASSOCIATED WITH URINARY INCONTINENCE: PRELIMINARY RESULTS OF A RANDOMISED STUDY
  70. SEXUAL REHABILITATION AFTER RADICAL RETROPUBIC PROSTATECTOMY: A RANDOMISED PROSPECTIVE STUDY ON VACUUM DEVICE + SILDENAFIL VS. ALPROSTADIL + SILDENAFIL
  71. INCONTINENCE AFTER COLPOSUSPENSION DURING SACROPEXY: PRELIMINARY RESULTS OF A RANDOMISED STUDY
  72. Treatment of Urethral Syndrome: A Prospective Randomized Study with Nd:YAG Laser
  73. Uterus Preservation in Surgical Correction of Urogenital Prolapse
  74. Recovery of sexual function after nerve-sparing radical retropubic prostatectomy: is cavernous nitric oxide level a prognostic index?
  75. 718CYP17 polymorphisms and prostate cancer
  76. 488Abdominal sacropexy with uterine conservation for women with uterovaginal prolapse: An evolving concept
  77. 815Nerve growth factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor over activity treated with tamsulosin
  78. Impact of different sized catheters on pressure-flow studies in women with lower urinary tract symptoms
  79. Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer
  80. Assessing outcome after a modified vaginal wall sling for stress incontinence with intrinsic sphincter deficiency
  81. ASSESSMENT OF BLADDER AND URETHRAL SPHINCTER FUNCTION BEFORE AND AFTER RADICAL RETROPUBIC PROSTATECTOMY
  82. 857 Association of CYP17, GSTP1, PON1-55 and PON1-192 polymorphisms with prostate cancer risk
  83. 81 Prostasomes and prostate cancer
  84. 190 Colposacropexy: Our experience
  85. 219 Intermittent androgen suppression in prostate cancer: Really intermittent?
  86. Stage pT1 renal cell carcinoma: review of the prognostic significance of size
  87. Lichen Sclerosus of the Male Genitalia and Urethral Stricture Diseases
  88. Renal cell carcinoma: histological findings on surgical margins after nephron sparing surgery
  89. Color Doppler Ultrasonography in the Diagnosis of Vascular Abnormalities Associated with Ureteropelvic Junction Obstruction
  90. Renal Cell Carcinoma: Histological Findings on Surgical Margins After Nephron Sparing Surgery
  91. Uterus preservation in surgical correction of uro-genital prolapse
  92. TGF-Beta and prostate cancer: A reliable marker?
  93. Echo-colour doppler in the diagnosis of vascular abnormalities associated with uteropelvic junction obstruction
  94. Stage pT1 Renal Cell Carcinoma: Review of the Prognostic Significance of Size
  95. Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas
  96. PRIMARY BURKITT???S LYMPHOMA OF BLADDER IN PATIENT WITH AIDS
  97. PRIMARY BURKITT’S LYMPHOMA OF BLADDER IN PATIENT WITH AIDS
  98. Puma vs romanzi in the detection of female bladder obstruction and detrusor contractility
  99. Elective conservative surgery and renal tumour multifocality: our experience
  100. Linking age, cystocele and abdominal straining
  101. Stage PT1 renal cell carcinoma: review of the prognostic significance of size
  102. Peyronie’s Disease: Corporoplasty Using Saphenous Vein Patch Graft
  103. Is the Q-tip test reliable in the diagnosis of urethral mobility?
  104. BIOFEEDBACK SUCCESSFULLY CURES DETRUSOR-SPHINCTER DYSSYNERGIA IN PEDIATRIC PATIENTS
  105. Detubularized rectosigmoid neobladder in women after cystectomy for bladder cancer
  106. Ureterointestinal Anastomosis in Orthotopic Neobladders
  107. Detubularized rectosigmoid neobladder in women after cystectomy for bladder cancer
  108. Penile Prosthesis Implantation and Couple’s Satisfaction
  109. Open Prostatectomy in Benign Prostatic Hyperplasia: 10-Year Experience in Italy
  110. Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacin
  111. Vagal control of lymphocyte release from rat thymus